Acute myocarditis following mRNA COVID‐19 vaccination was reported by the European
Medicine Agency safety committee as a rare adverse event. We present a case series of …

Background Myocarditis has been reported following the first two doses of Pfizer-BNT162b2
messenger RNA (mRNA) COVID-19 vaccination. Administration of a third dose (booster) of …

Background and aims Recent media reports of myocarditis after receiving COVID-19
vaccines, particularly the messenger RNA (mRNA) vaccines, are causing public concern …

Dear Editor, Myocarditis has emerged as a rare complication of coronavirus disease 2019
(COVID-19) mRNA vaccinations, particularly in young males [1]. Myocarditis following …

Background: Several cases of myocarditis associated with COVID-19 mRNA vaccines have
recently been reported in which the mechanism of vaccine-induced myocarditis has not …

Background The worldwide spread of coronavirus disease 2019 (COVID-19) is still not
under control and vaccination in Japan started in February 2021, albeit later than in Europe …

Introduction Reports of SARS-CoV-2 coronavirus (COVID-19) vaccine-related myocarditis,
particularly after mRNA vaccines, have raised concerns amongst the general public. This …

A new trend of myocarditis among young adults who received mRNA vaccines for COVID-19
is emerging. We present the case of a young adult who presented with chest pain 3 days …

Vaccines against coronavirus 2019 disease (COVID-19) have shown to be greatly effective
in preventing viral spread, serious illness and death from this infectious disease and are …

Since the beginning of the COVID-19 (Coronavirus Disease of 2019) pandemic, myocarditis
has received much attention and controversy as one of the more worrisome cardiovascular …